USFDA inspects Sharon Bio-Medicine's Taloja unit

Drug firm Sharon Bio-Medicine's Taloja facility in Maharashtra that manufactures active pharmaceutical ingredients (API) has been inspected by the US health regulator.

One of the company's unit located at Taloja in Raigad district in Maharashtra has been inspected and audited by United States Food and Drug Administration (USFDA) inspectors for 7 days starting from June 29, 2015, Sharon Bio-Medicine said in a filing to BSE.

The audit was completed on July 7, 2015, it added. The company however did not provide any details about the findings of the inspection.

Earlier the USFDA had issued a warning letter to the owner of the firm for failing to pay the appropriate facility fee for its Dehradun based facility as required by the Generic Drug User Fee Amendments of 2012 (GDUFA).

Shares of Sharon Bio-Medicine today closed at Rs 20.38 per scrip on BSE, up 3.56 per cent from its previous close.